TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05645536 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06634797 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT05710328 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06205771 — Predictive Biomarker (PRD): GPER1 mRNA
Genes: GPER1; CEPR; CMKRL2; DRY12; GPER; GPR30
Study NCT06205771 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT06205771 — Predictive Biomarker (PRD): YAP1 mRNA
Genes: YAP1; YAP65
Study NCT05799508 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06308718 — Predictive Biomarker (PRD): GALC mRNA
Genes: GALC
Study NCT05098197 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05732831 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT05869773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04923542 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04923542 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04923542 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05952037 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT04984876 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04181333 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05732428 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05732428 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05732428 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05732428 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05600426 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT05600426 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT05703737 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04922333 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05378464 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03850964 — Surrogate Endpoint (SUR): Hemoglobin response rate
Study NCT04844073 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04633811 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05903807 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06478693 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05585320 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT05484882 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05799638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06521554 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05901051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05834517 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06217822 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05090566 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05216432 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05216432 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05938023 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05546268 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT05546268 — Predictive Biomarker (PRD): GSPT1 mRNA
Genes: GSPT1; ERF3A
Study NCT05546268 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05546268 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05546268 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04659863 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04659863 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05739643 — Predictive Biomarker (PRD): GALC mRNA
Genes: GALC
Study NCT06492707 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT06029296 — Predictive Biomarker (PRD): KMO mRNA
Genes: KMO
Study NCT06232642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06494540 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06494540 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT06494540 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06494540 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06494540 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05473767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05861960 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT06018129 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05369000 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05369000 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06170346 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05536752 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04910152 — Predictive Biomarker (PRD): BRD4 mRNA
Genes: BRD4; HUNK1
Study NCT05326451 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05843552 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT04837222 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05530395 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05222971 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06489041 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT05659901 — Predictive Biomarker (PRD): PLP1 mRNA
Genes: PLP1; PLP
Study NCT04942015 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05844475 — Predictive Biomarker (PRD): BSG mRNA
Genes: BSG; UNQ6505/PRO21383
Study NCT06534060 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT04828382 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05627245 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06223256 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT06016387 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06243744 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05492955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05601700 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05461664 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT05614739 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT05792085 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05552326 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05172011 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05669664 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06129539 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study NCT06321510 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05098184 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04680468 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05586061 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06560138 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06121479 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05622929 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05509413 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05737940 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05737940 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06439498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06042569 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04773522 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06194929 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06194929 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05158205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05158205 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05196815 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT05607550 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05607550 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05079919 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04939935 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT06253494 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06299410 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT06299410 — Safety Biomarker (SAF): DRD2
Study NCT05523206 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study NCT06202521 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05784753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05006716 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06330064 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06396260 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05514717 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04733040 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06382948 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06382948 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06382948 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05642143 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06558604 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04915989 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05132075 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04815213 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05299242 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04988269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05831176 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05831176 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04717752 — Predictive Biomarker (PRD): GNS mRNA
Genes: GNS
Study NCT04717752 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT06052631 — Predictive Biomarker (PRD): PIEZO2 mRNA
Genes: PIEZO2; C18orf30; C18orf58; FAM38B
Study NCT06287762 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT06287762 — Safety Biomarker (SAF): RYR1
Genes: RYR; PPP1R137
Study NCT06161558 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04729959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05655312 — Predictive Biomarker (PRD): MC1R mRNA
Genes: MC1R; MSHR
Study NCT04548752 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04548752 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04977986 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study NCT06655493 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04447911 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04447911 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04447911 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06447272 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06077864 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04745559 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05939128 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05939128 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06422507 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06422507 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06565572 — Predictive Biomarker (PRD): FLVCR1 mRNA
Genes: FLVCR1; FLVCR
Study NCT06249048 — Predictive Biomarker (PRD): ST8SIA2 mRNA
Genes: ST8SIA2; SIAT8B; STX
Study NCT05554380 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT06015880 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study NCT06757634 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06757634 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06757634 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04671212 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06345404 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study NCT06760741 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT06522919 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT05756088 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06760858 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06507748 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04956744 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05256225 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04858334 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04858334 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04858334 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04569591 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT06555562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06552767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06762353 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05675410 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05987241 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06547151 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04906395 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04906395 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04906395 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04906395 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05374603 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05374603 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06560463 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06762132 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03843190 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05161715 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06151574 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04937062 — Predictive Biomarker (PRD): STXBP1 mRNA
Genes: STXBP1; UNC18A
Study NCT05744687 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05744687 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06346392 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05621291 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT04704674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05897190 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05383079 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06431633 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06452277 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06559176 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06559176 — Predictive Biomarker (PRD): NCF1 mRNA
Genes: NCF1; NOXO2; SH3PXD1A
Study NCT05928078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05852405 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05852405 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT05852405 — Predictive Biomarker (PRD): TARDBP mRNA
Genes: TARDBP; TDP43
Study NCT06345339 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05318898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04345913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06469281 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05249881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05539365 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05754333 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05216588 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06193200 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT05275478 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT05482178 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05482178 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT06365853 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT04967248 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04967248 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05827081 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05827081 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06492291 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05836584 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05677308 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06578624 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT06578624 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06337318 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06337318 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04759586 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05958121 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT05213572 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06360354 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT06297226 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06651476 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT05889247 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05764733 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06421636 — Predictive Biomarker (PRD): TMPRSS6 mRNA
Genes: TMPRSS6; UNQ354/PRO618
Study NCT06421636 — Predictive Biomarker (PRD): Liver iron
Study NCT06502171 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05445843 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05445843 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT06118034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06118034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06118034 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06118034 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06118034 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT06118034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06118034 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06118034 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06118034 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05789173 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT05789173 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04538378 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04538378 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04793646 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05818553 — Predictive Biomarker (PRD): SCN2A mRNA
Genes: SCN2A; NAC2; SCN2A1; SCN2A2
Study NCT05818553 — Predictive Biomarker (PRD): SCN8A mRNA
Genes: SCN8A; MED
Study NCT04679935 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04679935 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04679935 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05685173 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05685173 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT06515912 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT06515912 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06224673 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05789082 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05646836 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05039866 — Predictive Biomarker (PRD): GLA
Genes: GALA